Join us for an educational session that begins with an introduction to the Multiple Myeloma Research Foundation (MMRF) and its mission, followed by an in-depth look at two innovative therapies: CAR T-cell therapy and bispecific antibodies. Learn what defines early and late relapsed/refractory multiple myeloma, explore available treatment options, and understand what patients can expect when undergoing CAR T or bispecific antibody therapy. The presentation will conclude with a Q&A.

Presented by: Grace Allison, RN, BSN, OCN, Patient Navigator at Multiple Myeloma Research Foundation

This lecture is in lieu of the Center’s monthly Multiple Myeloma Networking Group.

Registration closes at 2:00 pm on December 3rd.

An email with log-in instructions will be sent before the program.